Effect of L-lysine on nitric oxide overproduction in endotoxic shock

British Journal of Pharmacology

Volumn 122, Issue 4, 1997, Pages 742-748

  Liaudet, Lucas ^a   Gnaegi, Alex ^a   Rosselet, Anne ^a   Markert, Michèle ^a   Boulat, Olivier ^a   Perret, Claude ^a   Feihl, François ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Endothelial constitutive nitric oxide synthase; Endotoxic shock; Inducible nitric oxide synthase; L arginine; L lysine; Lipopolysaccharide; Nitric oxide; System y+

Indexed keywords

ALANINE AMINOTRANSFERASE; ARGININE; CITRULLINE; CREATININE; LACTIC ACID; LIPOPOLYSACCHARIDE; LYSINE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRIACYLGLYCEROL LIPASE; UREA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FORWARD HEART FAILURE; HYPERLACTATEMIA; HYPOTENSION; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SEPTIC SHOCK;

ANIMALS; HEMATOCRIT; HEMODYNAMIC PROCESSES; LACTIC ACID; LYSINE; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR; SHOCK, SEPTIC;

EID: 0030694069     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701419     Document Type: Article

References (43)

1. BALLIGAND, J.L., KELLY, R.A., MARSDEN, P.A., SMITH, T.W. & MICHEL, T. (1993). Control of cardiac muscle cell function by an endogenous nitric oxide signalling system. Proc. Natl. Acad. Sci. U.S.A., 90, 347-351.
2. BIANCHI, M., ULRICH, P., BLOOM, O., MEISTRELL, M., ZIMMERMAN, G.A., SCHMIDTMAYEROVA, H., BUKRINSKY, M., DONNELLEY, T., BUCALA, R., SHERRY, B., MANOGUE, K.R., TORTOLANI, A.J., CERAMI, A. & TRACEY, K.J. (1995). An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality. Mol. Med., 1, 254-266.
3. BLATTBERG, B. & LEVY, M.N. (1969). Nature of bradycardia evoked by bacterial endotoxin. Am. J. Physiol., 216, 249-253.
4. BOGLE, R.G., BAYDOUN, A.R., PEARSON, J.D., MONCADA, S. & MANN, G.E. (1992). L-Arginine transport is increased in macrophages generating nitric oxide. Biochem. J., 284, 15-18.
5. BUNE, A.J., SHERGILL, J.K., CAMMACK, R. & COOK, H.T. (1995). L-Arginine depletion by arginase reduces nitric oxide production in endotoxic shock: an electron paramagnetic resonance study. FEBS Lett., 366, 127-130.
6. COBB, J.P., NATANSON, C., QUEZADO, Z.M.N., HOFFMAN, W.D., KOEV, C.A., BANKS, S., CORREA, R., LEVI, R., ELIN, R.J., HOSSEINI, J.M. & DANNER, R.L. (1995). Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs. Am. J. Physiol., 268, H1634-H1642.
7. DURANTE, W., LIAO, L., IFTIKHAR, I., O'BRIEN, W.E. & SCHAFER, A.I. (1996). Differential regulation of L-arginine transport and nitric oxide production by vascular smooth muscle and endothelium. Circ. Res., 78, 1075-1082.
8. DURANTE, W., LIAO, L. & SCHAFER, A. (1995). Differential regulation of L-arginine transport and inducible NOS in cultured vascular smooth muscle cells. Am. J. Physiol., 268, H1158-H1164.
9. FISHMAN, D., LIAUDET, L., LAZOR, R., FEIHL, F. & PERRET, C. (1997). L-Canavanine, an inhibitor of inducible nitric oxide synthase, improves venous return in endotoxemic rats. Crit. Care Med., 25, 469-475.
10. GEROULANOS, S., SCHILLING, J., CAKMAKCI, M., JUNG, H.H. & LARGIADER, F. (1992). Inhibition of NO synthesis in septic shock. Lancet, 339, 435.
11. HALINEN, M. (1976). Initial effects of endotoxin on cardiovascular reflex functions and circulation in dogs. Acta Physiol. Scand., Suppl. 439, 1-61.
12. HAN, X., SHMONI, Y. & GILES, W.R. (1994). An obligatory role for nitric oxide in autonomic control of mammalian heart rate. J. Physiol., 476, 309-314.
13. HARBRECHT, B.G., BILLIAR, T.R., STADLER, J., DEMETRIS, A.J. OCHOA, J., CURRAN, R.D. & SIMMONS, R.L. (1992). Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J. Leukoc. Biol., 52, 390-394.
14. HOTCHKISS, R.S. & KARL, I.E. (1992). Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. J. Am. Med. Assoc., 267, 1503-1510.
15. ISOYAMA, T., SATO, T., TANAKA, J. & SHATNEY, C.H. (1982). Measurement of cardiac output in small animals by aortic thermodilution. J. Surg. Res., 33, 170-176.
16. KARZAI, W., REILLY, J.M., HOFFMAN, W.D., CUNNION, R.E., DANNER, R.L., BANKS, S.M., PARILLO, J.E. & NATANSON, C. (1995). Hemodynamic effects of dopamine, norepinephrine, and fluids in a dog model of sepsis. Am. J. Physiol., 268, H692-H702.
17. KATO, T., SANO, M. & MIZUTANI, N. (1987). Inhibitory effect of intravenous lysine infusion on urea cycle metabolism. Eur. J. Pediatr., 146, 56-58.
18. KITAJIMA, S. & KISHINO, Y. (1985). Pancreatic damage produced by injecting excess lysine in rats. Virchows Arch. (Cell Pathol)., 49, 295-305.
19. LEVY, M.N. & BLATTBERG, B. (1967). Changes in heart rate induced by bacterial endotoxin. Am. J. Physiol., 213, 1485-1492.
20. LIAUDET, L., FEIHL, F., ROSSELET, A., MARKERT, M. & PERRET, C. (1996). Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, during rodent endotoxemia. Clin. Sci., 90, 369-377.
21. LIAUDET, L., FISHMAN, D., MARKERT, M., PERRET, C. & FEIHL, F. (1997). L-Canavanine improves organ function and tissue adenosine triphosphate levels in rodent endotoxemia. Am. J. Respir. Crit. Care Med., 155, 1643-1648.
22. MACARTHUR, H., MATTAMAL, M.B. & WESTFALL, T.C. (1995). A new perspective on the inhibitory role of nitric oxide in sympathetic neurotransmission. Biochem. Biophys. Res. Commun., 216, 686-692.
23. MITCHELL, J.A., HECKER, M., ANGGARD, E.A. & VANE, J.R. (1990). Cultured endothelial cells maintain their L-arginine levels despite the continuous release of EDRF. Eur. J. Pharmacol., 182, 573-576.
24. MONCADA, S. & HIGGS, A. (1993). The L-arginine-nitric oxide pathway. N. Engl. J. Med., 329, 2002-2012.
25. PARRATT, J.R. (1973). Myocardial and circulatory effects of E. coli endotoxin; modification of responses to catecholamines. Br. J. Pharmacol., 47, 12-25.
26. PAYEN, D., BERNARD, C. & BELOUCIF, S. (1996). Nitric oxide and sepsis. Clin. Chest Med., 17, 333-350.
27. PETROS, A., BENNETT, D. & VALLANCE, P. (1991). Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet, 338, 1557-1558.
28. PETROS, A., LAMB, G., LEONE, A., MONCADA, S., BENNETT, D. & VALLANCE, P. (1994). Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc. Res., 28, 34-39.
29. RACUSEN, L.C., WHELTON, A. & SOLEZ, K. (1985). Effects of lysine and other amino acids on kidney structure and function in the rat. Am. J. Pathol., 120, 436-442.
30. RUETTEN, H., SOUTHAN, G.J., ABATE, A. & THIEMERMANN, C. (1996). Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br. J. Pharmacol., 118, 261-270.
31. SCHOTT, C.A., GRAY, G.A. & STOCLET, J.C. (1993a). Dependence of endotoxin-induced vascular hyporeactivity on extracellular L-arginine. Br. J. Pharmacol., 108, 38-43.
32. SCHOTT, C.A., VETROVSKY, P. & STOCLET, J.C. (1993b). Cationic amino acids inhibit the effects of L-argininc in rat aorta exposed to lipopolysaccharide. Eur. J. Pharmacol., 236, 155-157.
33. SCHWARZ, P., DIEM, R., DUN, N.J. &. FORSTERMAN, U. (1995). Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves. Circ. Res., 77, 841-848.
34. SHINDO, T., IKEDA, U., OHKAWA, F., TAKAHASHI, M., FUNAYAMA, H., NISHINAGA, M., KAWAHARA, Y., YOKOYAMA, M., KASAHARA, T. & SHIMADA, K. (1994). Nitric oxide synthesis in rat cardiac myocytes and fibroblasts. Life Sci., 55, 1101-1108.
35. SOUTHAN, J. & SZABO, C. (1996). Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem. Pharmacol., 51, 383-394.
36. SZABO, C. (1995). Alterations in nitric oxide production in various forms of circulatory shock. New Horizons, 3, 2-32.
37. SZABO, C. SOUTHAN, G.J. & THIEMERMANN, C. (1994). Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A., 91, 12472-12476.
38. TAO, S. & MCKENNA, T.M. (1994). In vitro endotoxin exposure induces contractile dysfunction in adult rat cardiac myocytes. Am. J. Physiol., 267, H1745-H1752.
39. THOMAS, G., HECKER, M. & RAMWELL, P. (1989). Vascular activity of polycations and aminoacids: L-arginine does not specifically elicit endothelium-dependent relaxation. Biochem. Biophys. Res. Commun., 158, 177-180.
40. WHITE, M.F. (1985). The transport of cationic amino acids across the plasma membrane of mammalian cells. Biochim. Biophys. Acta, 822, 355-374.
41. WRIGHT, C.E., REES, D.D. & MONCADA, S. (1992). Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res., 26, 48-57.
42. WU, C.C., CHEN, S.J., SZABO, C., THIEMERMANN, C. & VANE, J.R. (1995). Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br. J. Pharmacol., 114, 1666-1672.
43. WU, C.C., RUETTEN, H. & THIEMERMANN, C. (1996). Comparison of the effects of aminoguanidine and N-omega-nitro-L-arginine methyl ester on the multiple organ dysfunction caused by endotoxaemia in the rat. Eur. J. Pharmacol., 300, 99-104.